BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 7773544)

  • 21. Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.
    Brown CA; Loweth AC; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Feb; 108(2):312-7. PubMed ID: 8095415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration.
    Alemany R; Olmos G; Escribá PV; Menargues A; Obach R; García-Sevilla JA
    Eur J Pharmacol; 1995 Jul; 280(2):205-10. PubMed ID: 7589187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated idazoxan increases brain imidazoline receptors in normotensive (WKY) but not in hypertensive (SHR) rats.
    Olmos G; Miralles A; Barturen F; García-Sevilla JA
    J Neurochem; 1991 Nov; 57(5):1811-3. PubMed ID: 1681037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system.
    De Vos H; Bricca G; De Keyser J; De Backer JP; Bousquet P; Vauquelin G
    Neuroscience; 1994 Apr; 59(3):589-98. PubMed ID: 8008210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; McIntyre IM; White K
    J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]idazoxan binding to bovine adrenal medullary membranes: identification and pharmacological characterization of I2-imidazoline sites.
    Molderings GJ; Kundt L; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):252-7. PubMed ID: 7824041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-dependent increases of immunoreactive imidazoline receptors in the human brain: possible association of a 29/30 kDa protein with the I2-imidazoline receptor identified by [3H]idazoxan.
    García-Sevilla JA; Sastre M; Escribá PV
    Neurosci Lett; 1995 Jan; 184(2):133-6. PubMed ID: 7724047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of imidazoline receptors in blood pressure regulation.
    Hamilton CA
    Pharmacol Ther; 1992; 54(3):231-48. PubMed ID: 1361236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. I2-imidazoline receptors in the healthy and pathologic human brain.
    García-Sevilla J; Miralles A; Sastre M; Escribá PV; Olmos G; Meana JJ
    Ann N Y Acad Sci; 1995 Jul; 763():178-93. PubMed ID: 7677330
    [No Abstract]   [Full Text] [Related]  

  • 33. [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes.
    Cesura AM; Imhof R; Takacs B; Galva MD; Picotti GB; Da Prada M
    J Neurochem; 1988 Apr; 50(4):1037-43. PubMed ID: 3126263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain.
    Escribá PV; Ozaita A; Miralles A; Reis DJ; García-Sevilla JA
    Brain Res Mol Brain Res; 1995 Sep; 32(2):187-96. PubMed ID: 7500830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
    Da Prada M; Keller HH; Kettler R
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():18-24. PubMed ID: 2587673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]-idazoxan binds with high affinity to two sites on hamster adipocytes: an alpha 2-adrenoceptor and a non-adrenoceptor site.
    MacKinnon AC; Brown CM; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1989 Dec; 98(4):1143-50. PubMed ID: 2558757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
    Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
    Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.
    Olmos G; Miralles A; Barturen F; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1000-7. PubMed ID: 1545372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imidazoline binding sites on PC12 cells and bovine chromaffin cells.
    Steffen G; Dendorfer A; Dominiak P
    Ann N Y Acad Sci; 1995 Jul; 763():157-62. PubMed ID: 7677325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.